JP1674350S - - Google Patents

Info

Publication number
JP1674350S
JP1674350S JPD2020-15395F JP2020015395F JP1674350S JP 1674350 S JP1674350 S JP 1674350S JP 2020015395 F JP2020015395 F JP 2020015395F JP 1674350 S JP1674350 S JP 1674350S
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JPD2020-15395F
Other languages
Japanese (ja)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to JPD2020-15395F priority Critical patent/JP1674350S/ja
Application granted granted Critical
Publication of JP1674350S publication Critical patent/JP1674350S/ja
Priority to US29/767,233 priority patent/USD966411S1/en
Priority to TW110300384F priority patent/TWD216108S/zh
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JPD2020-15395F 2020-07-22 2020-07-22 Active JP1674350S (enExample)

Priority Applications (3)

Application Number Priority Date Filing Date Title
JPD2020-15395F JP1674350S (enExample) 2020-07-22 2020-07-22
US29/767,233 USD966411S1 (en) 2020-07-22 2021-01-21 Pen
TW110300384F TWD216108S (zh) 2020-07-22 2021-01-22 原子筆之部分

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JPD2020-15395F JP1674350S (enExample) 2020-07-22 2020-07-22

Publications (1)

Publication Number Publication Date
JP1674350S true JP1674350S (enExample) 2020-12-07

Family

ID=73647252

Family Applications (1)

Application Number Title Priority Date Filing Date
JPD2020-15395F Active JP1674350S (enExample) 2020-07-22 2020-07-22

Country Status (3)

Country Link
US (1) USD966411S1 (enExample)
JP (1) JP1674350S (enExample)
TW (1) TWD216108S (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USD1042637S1 (en) * 2022-09-07 2024-09-17 Zhuhai Fengtaiyuan International Trade Co., Ltd. Pen

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USD431598S (en) 1998-09-21 2000-10-03 Ideo Product Development Combination stylus and pen
USD507599S1 (en) 2004-07-15 2005-07-19 Ningbo Beifa Group Co., Ltd. Pen
AU320097S (en) 2007-07-13 2008-07-01 Pentel Kk Ballpoint pen
JP1551235S (enExample) 2015-10-01 2016-06-13
USD818043S1 (en) * 2016-01-15 2018-05-15 Ningbo Johnshen Stationery Co., Ltd. Pen
JP1659750S (enExample) 2019-08-22 2020-05-18
JP1659749S (enExample) 2019-08-22 2020-05-18
JP1659748S (enExample) 2019-08-22 2020-05-18
USD949970S1 (en) * 2019-09-09 2022-04-26 Kabushiki Kaisha Pilot Corporation Ballpoint pen
JP1659765S (enExample) 2019-09-10 2020-05-18
USD942543S1 (en) * 2020-01-19 2022-02-01 Gary Lancet Combined bookmark and pen
JP1674323S (enExample) 2020-04-30 2020-12-07
JP1674327S (enExample) 2020-05-08 2020-12-07

Also Published As

Publication number Publication date
USD966411S1 (en) 2022-10-11
TWD216108S (zh) 2021-12-21

Similar Documents

Publication Publication Date Title
CL2025002303A1 (es) Método de producción de una planta haploide duplicada.
JP1674323S (enExample)
BR102021007058A2 (enExample)
JP1674350S (enExample)
JP1674349S (enExample)
BR102020022030A2 (enExample)
AR134288A1 (es) UN PÉPTIDO CÍCLICO PARA ATRAPAR LA INTERLEUCINA-1b
AR134282A1 (es) Compuestos y composiciones farmacéuticas que degradan el regulador de la subfamilia a de la cromatina dependiente de actina asociado a la matriz relacionado con swi / snf
AR134275A1 (es) Anticuerpos cd24
AR134276A1 (es) ANTICUERPOS ANTI-MIGIS-a Y MÉTODOS DE USO DE ESTOS
AR134271A1 (es) Variantes de cnp, conjugados y formulaciones de los mismos
AR134266A1 (es) Métodos para tratar el cáncer utilizando compuestos que inhiben la pkmyt1
AR134264A1 (es) Correctores farmacológicos de rodopsina y sus usos
AR134263A1 (es) Tratamiento de covid persistente con composición de vesículas extracelulares
AR134262A1 (es) Formulación líquida de agente biológico en almacenamiento estable
AR134259A1 (es) Compuestos de pirimidina bicíclicos, métodos y usos de estos
AR134257A1 (es) Degradadores bcl-xl heterobifuncionales de tetrahidroisoquinolina
AR134258A1 (es) Degradadores bcl-xl heterobifuncionales de tetrahidroisoquinolina
AR134219A1 (es) Derivados de (piperidin-4-il)-1,5-naftiridina y (piperidin-4-il)quinolina sustituidos y usos de los mismos
AR134214A1 (es) Redireccionamiento de cápsides de aav para dirigirlas al sistema nervioso central
AR134215A1 (es) Compuestos de tiazol y métodos de uso
AR134206A1 (es) Degradantes y usos de los mismos
AR134203A1 (es) Compuestos para la degradación de braf mutante
AR134200A1 (es) Combinaciones de herbicida / protector a base de herbicidas de la clase de las amidas de ácido n-(1,3,4-oxadiazol-2-il)fenilcarboxílico quirales y sus sales
AR134198A1 (es) Compuestos de proteasa 1 de procesamiento específico de ubiquitina (usp1)